CPM
GWPH

Chesapeake Partners Management’s GW Pharmaceuticals Plc American Depositary Shares GWPH Stock Holding History

Chesapeake Partners Management’s Portfolio GWPH Stock Details GWPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		– Sell
-105,200
Closed -$8.51M – 124
2014
Q3 		$8.51M Buy
105,200
+90,100
+597% +$7.97M 0.31% 77
2014
Q2 		$1.62M Buy
+15,100
New +$1.05M 0.05% 109

Other funds holding GWPH

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
PP
Prudential plc London, England, United Kingdom $17.1B AUM 15.7% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
MAA
Managed Account Advisors Jersey City, New Jersey $121B AUM 7.32% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Chesapeake Partners Management's GWPH Position: Q2 2015 in Review

Chesapeake Partners Management sold out of GW Pharmaceuticals Plc American Depositary Shares (GWPH) in Q2 2015, closing a stake of 30,000 shares — an estimated $2.73M sold.

Chesapeake Partners Management first reported a position in GWPH in Q1 2014 and held it in 5 quarters. The position peaked at $38M in Q2 2014. 104 funds tracked by Wall St. Rank hold GWPH as of Q2 2015.

  • Chesapeake Partners Management reported no remaining GW Pharmaceuticals Plc American Depositary Shares position as of Q2 2015 after selling out during the quarter.
  • Chesapeake Partners Management sold 30,000 GW Pharmaceuticals Plc American Depositary Shares shares in Q2 2015, an estimated $2.73M.
  • Chesapeake Partners Management first reported a position in GW Pharmaceuticals Plc American Depositary Shares in Q1 2014 and held it in 5 quarters.
  • Chesapeake Partners Management's GW Pharmaceuticals Plc American Depositary Shares position peaked at $38M in Q2 2014.
  • 104 funds tracked by Wall St. Rank held GW Pharmaceuticals Plc American Depositary Shares as of Q2 2015.

Based on Chesapeake Partners Management's 13F filing for Q2 2015, filed 14 Aug 2015.